Dietary and Blood Lipids in Cardiovascular Disease

Main Article Content

Sheikh Salahuddin Ahmed

Abstract

Blood lipids are essential for life; at the same time, elevated or reduced levels of some of the components of lipid are related to risk of atherosclerotic cardiovascular disease (ASCVD). This article provides a review on dietary and blood lipids with their impact on cardiovascular health. The role of apolipoprotein B (ApoB), Lipoprotein(a) ((Lp(a)) and other lipoprotein particles in the development of ASCVD has been reviewed. There are new evidences that ApoB the structural protein of most of the lipoprotein particles (carrier of blood lipids), in addition to low density lipoprotein-cholesterol (LDL-C), plays a central role in the pathogenesis of atherosclerosis with increased risk for ASCVD. Elevated levels of Lp(a) concentrations are associated with an increased risk of ASCVD, but it appears to be a weaker risk factor than ApoB or LDL-C.

Keywords:
LDC-cholesterol, Non-HDL-cholesterol, lipoprotein(a), apolipoprotein B, atherosclerotic cardiovascular disease

Article Details

How to Cite
Ahmed, S. S. (2020). Dietary and Blood Lipids in Cardiovascular Disease. Journal of Advances in Medicine and Medical Research, 32(2), 11-21. https://doi.org/10.9734/jammr/2020/v32i230362
Section
Review Article

References

Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256: 2835-2838.

Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber RT. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med. 1977;62:707-714.

National Cholesterol Education Program (NCEP) Expert Panel. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics--2015 update: A report from the American Heart Association. Circulation. 2015;131:e29-322.

Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb. 2003;10(2):63-71.

Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Annals of the New York Academy of Sciences. 2000; 902:230-239.

Williams KJ, Tabas I. The response-to-retention hypothesis of early athero-genesis. Arterioscler Thromb Vasc Biol. 1995;15(5):551-561.

Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet: IV. Particular saturated fatty acids in the diet. Metabolism. 1965;14:776-787.

Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC Jr, Dai D, et al. Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get with The Guidelines. American Heart Journal. 2009; 157:111-117.

Binder HJ, Reuben A. Nutrient digestion and absorption. In: Medical physiology: A cellular and molecular approach, edited by, Boron WF, Boulpaep EL. Philadelphia, PA: Saunders. 2009;949–979.

Lowe ME. The triglyceride lipases of the pancreas. J Lipid Res. 2002;43(12):2007-2016.

Goodman BE. Insights into digestion and absorption of major nutrients in humans. Adv Physiol Educ. 2010;34(2):44-53.

Kris-Etherton PM. Monounsaturated fatty acids and risk of cardiovascular disease. Circulation. 1999;100:1253-1258.

Endo J, Arita M. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. J Cardiol. 2016;67(1):22-27.

Desnoyers M, Gilbert K, Rousseau G. Cardioprotective effects of omega-3 polyunsaturated fatty acids: Dichotomy between experimental and clinical studies. Mar Drugs. 2018;16(7)pii:E234.

Willett WC. The role of dietary n-6 fatty acids in the prevention of cardiovascular disease. Journal of Cardiovascular Medicine. 2007;8(Suppl 1):S42-45.

Blesso CN, Fernandez ML. Dietary cholesterol, serum lipids and heart disease: Are eggs working for or against you? Nutrients. 2018;10(4)pii:E426.

Zhong VW, Van Horn L, Cornelis MC, Wilkins JT, Ning H, Carnethon MR, et al. Associations of dietary cholesterol or egg consumption with incident cardiovascular disease and mortality. JAMA. 2019; 321(11):1081-1095.

US Department of Agriculture. Agricultural Research Service, Nutrient Data Laboratory. USDA National Nutrient Database for Standard Reference, Release 28. Version Current; 2015.
Available:https://ndb.nal.usda.gov/ndb
(Accessed Nov 16, 2019)

Iqbal J, Hussain MM. Intestinal lipid absorption. Am J Physiol Endocrinol Metab. 2009:296:E1183-E1194.

Feingold KR, Grunfeld C. Introduction to lipids and lipoproteins. [Updated 2018 Feb 2]. In: Feingold KR, Anawalt B, Boyce A, et al. editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.
Available:https://www.ncbi.nlm.nih.gov/books/NBK305896/
[Accessed Jan 17, 2020]

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal. 2019;1-78.

Linton MRF, Yancey PG, Davies SS, Jerome WG, Linton EF, Song WL, et al. The role of lipids and lipoproteins in atherosclerosis. 2019 Jan 3. In: Feingold KR, Anawalt B, Boyce A, et al. editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.
Available:https://www.ncbi.nlm.nih.gov/books/NBK343489
(Accessed Sep 15, 2019)

Olofsson SO, Borèn J. Apolipoprotein B: A clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of athero-sclerosis. J Intern Med. 2005;258(5):395-410.

McNamara DJ, Kolb R, Parker TS, Batwin H, Samuel P, Brown CD, et al. Heterogeneity of cholesterol homeostasis in man. Response to changes in dietary fat quality and cholesterol quantity. J. Clin. Investig. 1987;79:1729-1739.

Bosner MS, Lange LG, Stenson WF, Ostlund RE Jr. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J. Lipid Res. 1999;40:302-308.

Ikonen, E. Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol. 2008;9:125-138.

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracen-trifuge. Clin Chem. 1972;18(6):499-502.

Sathiyakumar V, Park J, Golozar A, Lazo M, Quispe R, Guallar E, et al. Fasting versus nonfasting and low-density lipoprotein cholesterol accuracy. Circulation. 2018;137:10-19.

National Clinical Guideline Centre (UK). Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London: National Institute for Health and Care Excellence (UK); 2014.
Available:https://www.ncbi.nlm.nih.gov/books/NBK248067
(Accessed Aug 19, 2019)

Whitehead A, Beck EJ, Tosh S, Wolever TMS. Cholesterol-lowering effects of oat β-glucan: A meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014; 100:1413-1421.

Contois JH, McConnell JP, Sethi AA, Csako G, Devaraj S, Hoefner DM, et al. Lipoproteins and vascular diseases division working group on best practices. Apolipoprotein B and cardiovascular disease risk: Position statement from the AACC lipoproteins and vascular diseases division working group on best practices. Clin Chem. 2009;55:407-419.

McKenney JR, EM. Statins. In: Ballantyne CM, ed. Clinical Lipidology, a companion to Braunwald’s heart disease. Second edition: Elsevier Saunders. 2015;227-256.

Koschinsky MLB, MB, Marcovina, SM. Lipoprotein(a). In: Ballantyne CM, ed. Clinical Lipidology, a companion to Braunwald’s Heart Disease. Second Edition: Elsevier Saunders. 2015;109-127.

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):3168- 3209.

Kannel WB, Wilson PWF. Efficacy of lipid profiles in prediction of coronary disease. Am Heart J. 1992;124:768-774.

Nam BH, Kannel WB, D'Agostino RB. Search for an optimal atherogenic lipid risk profile: From the Framingham study. Am J Cardiol. 2006;97(3):372-375.

Borén J, Williams KJ. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: A triumph of simplicity. Curr Opin Lipidol. 2016;27(5):473-483.

Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folsom AR, et al. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation. 1994;89(6): 2533-2539.

Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, et al. Major lipids, apolipoproteins and risk of vascular disease. JAMA. 2009;302(18): 1993-2000.

Andrews J, Janssan A, Nguyen T, Pisaniello AD, Scherer DJ, Kastelein JJ, et al. Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: Rationale and design of the CARAT study. Cardiovasc Diagn Ther. 2017;7:45-51.

Aim-High Investigators, Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365:2255-2267.

Nordestgaard BG, Chapman MJ, Ray K, Bore´n J, Andreotti F, Watts GF, et al. European atherosclerosis society consensus panel. Lipoprotein(a) as a cardiovascular risk factor: Current status. Eur Heart J. 2010;31:2844- 2853.

Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. On behalf of the American heart association clinical lipidology, Thrombosis and Prevention Committee of the Council on Nutrition, physical activity and metabolism, council on arteriosclerosis, thrombosis and vascular biology, Councilon Cardiovascular N. Triglycerides and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation. 2011;123:2292-2333.

Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am. 1990;19:783-791.

Zhuang P, Zhang Y, He W, Chen X, Chen J, He L, et al. Dietary fats in relation to total and cause-specific mortality in a prospective cohort of 521 120 individuals with 16 years of follow-up. Circ Res. 2019; 124(5):757-768.

Wilczek MM, Olszewski R, Krupienicz A. Trans-fatty acids and cardiovascular disease: Urgent need for legislation. Cardiology. 2017;138:254-258.

Clarke R, Frost C, Collins R, Appleby P, Peto R. Dietary lipids and blood cholesterol: Quantitative meta-analysis of metabolic ward studies. BMJ. 1997; 314(7074):112-117.

Carson JAS, Lichtenstein AH, Anderson CAM, Appel LJ, Kris-Etherton PM, Meyer KA, et al. Dietary cholesterol and cardiovascular risk: A science advisory from the American Heart Association. Circulation. 2019;140:[e-pub].
Available:https://doi.org/10.1161/CIR.0000000000000743